Thoracic kidney is a rare congenital abnormality, with the lowest frequency of all renal ectopias (< 5%) (
1-
3). This anomaly has been divided into four subtypes: with a closed diaphragm; with eventration of the diaphragm; with a diaphragmatic hernia (congenital or acquired); and with a traumatic diaphragmatic rupture (
4). The prevalence of thoracic renal ectopia related to congenital diaphragmatic hernia is less than 0.25% (
1-
3). Embryological theories, such as pleuroperitoneal fusion abnormalities or persistence of the mesonephric tissue, may explain the cause of congenital thoracic kidney (
4).
Patients with a thoracic kidney either present with no symptoms throughout their lives (
1-
3) or show dyspnea, flank pain, and intermittent cough (
3-
6). Regular follow-up is indicated in asymptomatic cases, while surgical treatment is recommended for children with respiratory distress, associated with a diaphragmatic defect and herniation (
1-
6). The differential diagnoses include neurogenic tumors, mediastinal lymphadenopathy, paraspinal abscess, aortic abscess, or esophageal pathologies (
1-
6).
Ultrasonography (USG) is the preferred method for evaluation of renal ectopia (
1-
3). Computed tomography (CT) or magnetic resonance imaging (MRI) may allow for a more accurate detection of renal and ureteral anatomies of a thoracic kidney (
7). Besides, renal scintigraphy in children is an excellent single modality for estimation of renal size, location, perfusion, parenchymal defects, differential renal function, drainage of the urinary tract, and excretion evaluation. Three radiopharmaceuticals, labelled with technetium-99m (
99mTc), are mainly used in dynamic renal scintigraphy studies, including diethylenetriaminepentaacetic acid (DTPA), mercaptoacethyltriglycine-3 (MAG-3), and ethylene dicysteine (EC) (
8,
9). 99mTc-DTPA is predominantly excreted by glomerular filtration, whereas
99mTc-MAG3 and
99mTc-EC are excreted almost exclusively by renal tubules.
MAG-3 and EC, as tubular radiopharmaceuticals, seem to be favorable for the assessment of kidney function due to the lower post-renal background activity and higher extraction rates in the kidneys. 99mTc–DTPA is a radiopharmaceutical used in the evaluation of filtration in glomerulonephritis or transplanted kidneys. According to the Polish National Ministry of Health Guidelines for Nuclear Medicine Procedures, all of the mentioned radiopharmaceuticals may be used in renal scintigraphy in children (
9). Due to the relatively high availability and favorable cost of EC, it is currently the most widely used radiopharmaceutical in renal scintigraphy studies in Poland, both in adults and children. According to the available Polish data, the average cost of one labeling viol of EC is 14.5% less than MAG.
Negligible accumulation in the liver is one of the greatest advantages of
99mTc-EC over
99mTc-MAG3 (
10). This feature is especially important when visualizing the kidneys in unusual locations, especially in the chest. It should be noted that radiation doses are similar for all radiopharmaceuticals (
Table 1), as presented in detail in the European and Polish guidelines for diuretic renography in children (
9,
11-
13). Also, EC is excreted faster from the body as compared to MAG-3 (EC: about 70% after 40 minutes and about 95% after 1.5 hours post-intravenous administration; MAG-3: about 70% after 30 minutes and 95% after three hours) (
9).
Here, we report three cases of thoracic kidneys in children and aimed to investigate the usefulness of 99mTc-EC renal scintigraphy in the evaluation of thoracic kidney function.